

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.26204341 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.26204341 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.26204341 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.26204341 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.26204341 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.26204341 |
| 7 | detection of molecule of bacterial origin (GO:0032490) | 5.94575771 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.63607857 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.59267599 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.59267599 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.36536022 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.33757862 |
| 13 | microglial cell activation (GO:0001774) | 5.05656432 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.99646582 |
| 15 | detection of other organism (GO:0098543) | 4.99357765 |
| 16 | cellular extravasation (GO:0045123) | 4.92241946 |
| 17 | detection of external biotic stimulus (GO:0098581) | 4.88526539 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.75207477 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.72527260 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.63662409 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.57773870 |
| 22 | response to peptidoglycan (GO:0032494) | 4.53847407 |
| 23 | synaptic vesicle maturation (GO:0016188) | 4.53030359 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.52884448 |
| 25 | locomotory exploration behavior (GO:0035641) | 4.51416919 |
| 26 | neuronal action potential propagation (GO:0019227) | 4.46392847 |
| 27 | vocalization behavior (GO:0071625) | 4.42887019 |
| 28 | macrophage activation (GO:0042116) | 4.41110312 |
| 29 | response to host immune response (GO:0052572) | 4.35130635 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.35130635 |
| 31 | detection of bacterium (GO:0016045) | 4.32289212 |
| 32 | detection of biotic stimulus (GO:0009595) | 4.27180436 |
| 33 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.26990284 |
| 34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.25996367 |
| 35 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.23747214 |
| 36 | neutrophil mediated immunity (GO:0002446) | 4.20736682 |
| 37 | synaptic vesicle exocytosis (GO:0016079) | 4.19541871 |
| 38 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.18676676 |
| 39 | glutamate secretion (GO:0014047) | 4.18275672 |
| 40 | neuron cell-cell adhesion (GO:0007158) | 4.16189160 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.14492144 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.10946216 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10045185 |
| 44 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.07363473 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07193162 |
| 46 | neutrophil activation (GO:0042119) | 4.03448662 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 4.02287297 |
| 48 | leukocyte aggregation (GO:0070486) | 3.95839881 |
| 49 | response to host (GO:0075136) | 3.95612936 |
| 50 | response to host defenses (GO:0052200) | 3.95612936 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95612936 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.94639028 |
| 53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.87963573 |
| 54 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.87611476 |
| 55 | protein localization to synapse (GO:0035418) | 3.87358478 |
| 56 | response to interleukin-15 (GO:0070672) | 3.84066290 |
| 57 | neuron recognition (GO:0008038) | 3.72207186 |
| 58 | exploration behavior (GO:0035640) | 3.68442938 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.68168448 |
| 60 | layer formation in cerebral cortex (GO:0021819) | 3.63894697 |
| 61 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.62402361 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.62283487 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 3.60944881 |
| 64 | respiratory burst (GO:0045730) | 3.59819731 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.57964730 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.57681127 |
| 67 | granulocyte activation (GO:0036230) | 3.56095296 |
| 68 | regulation of synaptic vesicle transport (GO:1902803) | 3.55030118 |
| 69 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.52910530 |
| 70 | axonal fasciculation (GO:0007413) | 3.52795557 |
| 71 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.52191825 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 3.51873444 |
| 73 | activated T cell proliferation (GO:0050798) | 3.50906185 |
| 74 | negative regulation of T cell mediated immunity (GO:0002710) | 3.49861613 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.49495639 |
| 76 | neurotransmitter secretion (GO:0007269) | 3.48942107 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.48275568 |
| 78 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.48096347 |
| 79 | glutamate receptor signaling pathway (GO:0007215) | 3.46973209 |
| 80 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45950368 |
| 81 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.42446904 |
| 82 | positive regulation of mast cell activation (GO:0033005) | 3.40778550 |
| 83 | dendrite morphogenesis (GO:0048813) | 3.37118275 |
| 84 | synaptic transmission, glutamatergic (GO:0035249) | 3.36883625 |
| 85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.36731746 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 3.35637568 |
| 87 | gamma-aminobutyric acid transport (GO:0015812) | 3.32225660 |
| 88 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.31993660 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29650271 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.27202448 |
| 91 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.25104044 |
| 92 | negative regulation of B cell mediated immunity (GO:0002713) | 3.22686091 |
| 93 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.22686091 |
| 94 | neuron-neuron synaptic transmission (GO:0007270) | 3.22169079 |
| 95 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.22145850 |
| 96 | cellular potassium ion homeostasis (GO:0030007) | 3.21701411 |
| 97 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.21459451 |
| 98 | proline transport (GO:0015824) | 3.20000764 |
| 99 | regulation of synapse structural plasticity (GO:0051823) | 3.17527330 |
| 100 | auditory behavior (GO:0031223) | 3.16599975 |
| 101 | regulation of mast cell activation (GO:0033003) | 3.16426874 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15208268 |
| 103 | transmission of nerve impulse (GO:0019226) | 3.12246774 |
| 104 | B cell receptor signaling pathway (GO:0050853) | 3.10488537 |
| 105 | presynaptic membrane assembly (GO:0097105) | 3.09052510 |
| 106 | regulation of leukocyte degranulation (GO:0043300) | 3.08517014 |
| 107 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04982278 |
| 108 | innervation (GO:0060384) | 3.02196604 |
| 109 | regulation of macrophage cytokine production (GO:0010935) | 3.01310018 |
| 110 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.00853687 |
| 111 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.00089664 |
| 112 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.99858263 |
| 113 | response to auditory stimulus (GO:0010996) | 2.99840086 |
| 114 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.99164265 |
| 115 | regulation of regulated secretory pathway (GO:1903305) | 2.97903004 |
| 116 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94631748 |
| 117 | positive regulation of mast cell degranulation (GO:0043306) | 2.94631748 |
| 118 | regulation of beta-amyloid formation (GO:1902003) | 2.93527395 |
| 119 | cerebellar granule cell differentiation (GO:0021707) | 2.92580943 |
| 120 | regulation of postsynaptic membrane potential (GO:0060078) | 2.92463303 |
| 121 | long-term memory (GO:0007616) | 2.92147236 |
| 122 | neutrophil chemotaxis (GO:0030593) | 2.92077850 |
| 123 | dendritic cell migration (GO:0036336) | 2.91167572 |
| 124 | neurotransmitter transport (GO:0006836) | 2.91003956 |
| 125 | postsynaptic membrane organization (GO:0001941) | 2.90712225 |
| 126 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.90566162 |
| 127 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.90525560 |
| 128 | regulation of synaptic plasticity (GO:0048167) | 2.89457021 |
| 129 | dendritic spine organization (GO:0097061) | 2.88681499 |
| 130 | activation of protein kinase A activity (GO:0034199) | 2.88357248 |
| 131 | positive regulation of macrophage cytokine production (GO:0060907) | 2.88328854 |
| 132 | presynaptic membrane organization (GO:0097090) | 2.88125301 |
| 133 | regulation of vesicle fusion (GO:0031338) | 2.87698334 |
| 134 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.86353299 |
| 135 | immunoglobulin mediated immune response (GO:0016064) | 2.86111803 |
| 136 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.85769920 |
| 137 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.85180099 |
| 138 | sodium ion export (GO:0071436) | 2.84860239 |
| 139 | neutrophil migration (GO:1990266) | 2.84858733 |
| 140 | mechanosensory behavior (GO:0007638) | 2.83777623 |
| 141 | negative regulation of type 2 immune response (GO:0002829) | 2.83732482 |
| 142 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.83209309 |
| 143 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.83017679 |
| 144 | regulation of cellular amide metabolic process (GO:0034248) | 2.82268928 |
| 145 | positive regulation of membrane potential (GO:0045838) | 2.81340413 |
| 146 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.81197159 |
| 147 | long-term synaptic potentiation (GO:0060291) | 2.81020455 |
| 148 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.80478926 |
| 149 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79861072 |
| 150 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.79613644 |
| 151 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.79613644 |
| 152 | leukocyte degranulation (GO:0043299) | 2.79033570 |
| 153 | positive regulation of interferon-alpha production (GO:0032727) | 2.78858874 |
| 154 | nerve growth factor signaling pathway (GO:0038180) | 2.78180428 |
| 155 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77257376 |
| 156 | negative regulation of interleukin-17 production (GO:0032700) | 2.75765923 |
| 157 | response to muramyl dipeptide (GO:0032495) | 2.75741327 |
| 158 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.75592821 |
| 159 | L-amino acid import (GO:0043092) | 2.75420086 |
| 160 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.75254024 |
| 161 | synapse assembly (GO:0007416) | 2.74910353 |
| 162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74570116 |
| 163 | myeloid leukocyte activation (GO:0002274) | 2.74029709 |
| 164 | cell migration in hindbrain (GO:0021535) | 2.73817251 |
| 165 | positive regulation of synapse maturation (GO:0090129) | 2.72528606 |
| 166 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.69897308 |
| 167 | negative regulation of adaptive immune response (GO:0002820) | 2.69562770 |
| 168 | regulation of neurotransmitter levels (GO:0001505) | 2.69337061 |
| 169 | synaptic vesicle endocytosis (GO:0048488) | 2.68707812 |
| 170 | positive regulation of regulated secretory pathway (GO:1903307) | 2.68266338 |
| 171 | neuromuscular process controlling balance (GO:0050885) | 2.68133431 |
| 172 | regulation of neurotransmitter secretion (GO:0046928) | 2.67595359 |
| 173 | neuronal ion channel clustering (GO:0045161) | 2.67354042 |
| 174 | membrane depolarization during action potential (GO:0086010) | 2.66848533 |
| 175 | chemosensory behavior (GO:0007635) | 2.66002862 |
| 176 | vesicle transport along microtubule (GO:0047496) | 2.65699337 |
| 177 | detection of calcium ion (GO:0005513) | 2.65482959 |
| 178 | defense response to protozoan (GO:0042832) | 2.65353243 |
| 179 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.64758201 |
| 180 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.64254367 |
| 181 | cell communication by electrical coupling (GO:0010644) | 2.63951046 |
| 182 | membrane depolarization (GO:0051899) | 2.62719127 |
| 183 | synapse organization (GO:0050808) | 2.62378363 |
| 184 | mating behavior (GO:0007617) | 2.59729653 |
| 185 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.58258976 |
| 186 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.55299750 |
| 187 | positive regulation of synapse assembly (GO:0051965) | 2.54746821 |
| 188 | adult walking behavior (GO:0007628) | 2.54218785 |
| 189 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.53666248 |
| 190 | learning (GO:0007612) | 2.52399673 |
| 191 | positive regulation of dendritic spine development (GO:0060999) | 2.52168284 |
| 192 | glycine transport (GO:0015816) | 2.51815089 |
| 193 | membrane hyperpolarization (GO:0060081) | 2.51459245 |
| 194 | organelle transport along microtubule (GO:0072384) | 2.51008835 |
| 195 | social behavior (GO:0035176) | 2.50567234 |
| 196 | intraspecies interaction between organisms (GO:0051703) | 2.50567234 |
| 197 | nucleobase catabolic process (GO:0046113) | 2.49288813 |
| 198 | regulation of dendritic spine development (GO:0060998) | 2.49210879 |
| 199 | axon ensheathment in central nervous system (GO:0032291) | 2.48234403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.37752002 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.13580783 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88040008 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66920280 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57637209 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.56887749 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45747915 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04049438 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99778039 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.97525603 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.87004475 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.84869556 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.78293894 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69274440 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60887327 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56415584 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52581718 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52581718 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45679115 |
| 20 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43544466 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42482006 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41938911 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40874265 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38989252 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37796019 |
| 26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34305120 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32563355 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25855258 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.24947739 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.21387332 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.20190312 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14900335 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14095707 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13767520 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08748463 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.08399490 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08210158 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02198435 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95894127 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90474933 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.88865916 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87296442 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85768444 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85237434 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81864545 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78209522 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.77561712 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75256820 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73540239 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67371089 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62523153 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61740263 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.60489918 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59240950 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58628334 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58439359 |
| 57 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50912353 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50649581 |
| 59 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50370729 |
| 60 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49910827 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47660774 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45970940 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45835260 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45129831 |
| 65 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.45051423 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43850610 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43313818 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.43311741 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42675351 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42223411 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40486278 |
| 72 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38609165 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38506632 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37300843 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36732716 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35770859 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35727576 |
| 78 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34019369 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33926310 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33369670 |
| 81 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33044829 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32657829 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32423884 |
| 84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32339943 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32309404 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 1.32284296 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31551089 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30907153 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30337965 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29924903 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29825515 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.29416656 |
| 93 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28235062 |
| 94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.27876642 |
| 95 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27860674 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27856459 |
| 97 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.27672522 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26786666 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26343560 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25893571 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23395273 |
| 102 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22313558 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21833456 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21066723 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19741592 |
| 106 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19419548 |
| 107 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18713908 |
| 108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17948426 |
| 109 | AR_19668381_ChIP-Seq_PC3_Human | 1.16424867 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16018783 |
| 111 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14216377 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14096364 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13804100 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13267903 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12931009 |
| 116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12006403 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11820776 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11722129 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11287188 |
| 120 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10750557 |
| 121 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09478797 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08505132 |
| 123 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07805060 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07650713 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06753582 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05743652 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05711203 |
| 128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05444015 |
| 129 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03216329 |
| 130 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03013301 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02676409 |
| 132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02515610 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02504017 |
| 134 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02217223 |
| 135 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02067419 |
| 136 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01898072 |
| 137 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01516626 |
| 138 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01074484 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99973943 |
| 140 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99941772 |
| 141 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99922642 |
| 142 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99095114 |
| 143 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99000214 |
| 144 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98123202 |
| 145 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98055422 |
| 146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97973655 |
| 147 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97565006 |
| 148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97464709 |
| 149 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96349091 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95710264 |
| 151 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95575885 |
| 152 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95575885 |
| 153 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.94297180 |
| 154 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93857880 |
| 155 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92742085 |
| 156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92582431 |
| 157 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92129865 |
| 158 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91734241 |
| 159 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91683474 |
| 160 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91395394 |
| 161 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90922947 |
| 162 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90374874 |
| 163 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90310000 |
| 164 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90165504 |
| 165 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90110378 |
| 166 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89043687 |
| 167 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88448010 |
| 168 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88086484 |
| 169 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88011197 |
| 170 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87300774 |
| 171 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85596809 |
| 172 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83843829 |
| 173 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82282715 |
| 174 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81699378 |
| 175 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81060413 |
| 176 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80274698 |
| 177 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76731949 |
| 178 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75486068 |
| 179 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75090787 |
| 180 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69984484 |
| 181 | MAF_26560356_Chip-Seq_TH2_Human | 0.69170594 |
| 182 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.68542813 |
| 183 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.66907914 |
| 184 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.65838944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.48126507 |
| 2 | MP0003724_increased_susceptibility_to | 5.47894147 |
| 3 | MP0003880_abnormal_central_pattern | 4.32934362 |
| 4 | MP0004270_analgesia | 3.86406693 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.66041279 |
| 6 | MP0003436_decreased_susceptibility_to | 3.57434508 |
| 7 | MP0003303_peritoneal_inflammation | 3.54020407 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.39223680 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.00005660 |
| 10 | MP0002419_abnormal_innate_immunity | 2.88792951 |
| 11 | MP0009745_abnormal_behavioral_response | 2.79794359 |
| 12 | MP0002064_seizures | 2.74987683 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.72977575 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.58930025 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.57834384 |
| 16 | MP0009046_muscle_twitch | 2.57504437 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.54635497 |
| 18 | MP0008260_abnormal_autophagy | 2.53240148 |
| 19 | MP0005025_abnormal_response_to | 2.46228093 |
| 20 | MP0002272_abnormal_nervous_system | 2.45164085 |
| 21 | MP0001800_abnormal_humoral_immune | 2.45017067 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.44082624 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.42815083 |
| 24 | MP0009785_altered_susceptibility_to | 2.42231139 |
| 25 | MP0000685_abnormal_immune_system | 2.41109997 |
| 26 | MP0001486_abnormal_startle_reflex | 2.40478918 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.36627794 |
| 28 | MP0006082_CNS_inflammation | 2.33509630 |
| 29 | MP0005000_abnormal_immune_tolerance | 2.32664034 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.27208119 |
| 31 | MP0005671_abnormal_response_to | 2.24450596 |
| 32 | MP0002735_abnormal_chemical_nociception | 2.21551956 |
| 33 | MP0005387_immune_system_phenotype | 2.20613834 |
| 34 | MP0001790_abnormal_immune_system | 2.20613834 |
| 35 | MP0003329_amyloid_beta_deposits | 2.15080951 |
| 36 | MP0002723_abnormal_immune_serum | 2.14840305 |
| 37 | MP0000778_abnormal_nervous_system | 2.10145713 |
| 38 | MP0002733_abnormal_thermal_nociception | 2.08558542 |
| 39 | MP0004883_abnormal_blood_vessel | 2.08238341 |
| 40 | MP0002420_abnormal_adaptive_immunity | 2.06907392 |
| 41 | MP0004381_abnormal_hair_follicle | 2.05544642 |
| 42 | MP0001819_abnormal_immune_cell | 2.03614836 |
| 43 | MP0003828_pulmonary_edema | 2.03601902 |
| 44 | MP0002452_abnormal_antigen_presenting | 2.03522452 |
| 45 | MP0006276_abnormal_autonomic_nervous | 2.02489127 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.94032296 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.91694163 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.90922977 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.90089177 |
| 50 | MP0002184_abnormal_innervation | 1.88155568 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.88011925 |
| 52 | MP0001970_abnormal_pain_threshold | 1.86247228 |
| 53 | MP0002736_abnormal_nociception_after | 1.85582865 |
| 54 | MP0004885_abnormal_endolymph | 1.81659346 |
| 55 | MP0008569_lethality_at_weaning | 1.78899096 |
| 56 | MP0004858_abnormal_nervous_system | 1.72815318 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.71175182 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.65949778 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.64362459 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.62592736 |
| 61 | MP0000955_abnormal_spinal_cord | 1.61171049 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.60215947 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.59053837 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.57856291 |
| 65 | MP0002405_respiratory_system_inflammati | 1.55925208 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.53827927 |
| 67 | MP0000920_abnormal_myelination | 1.53216738 |
| 68 | MP0005164_abnormal_response_to | 1.48024880 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.47892471 |
| 70 | MP0000716_abnormal_immune_system | 1.47818915 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.47006340 |
| 72 | MP0003075_altered_response_to | 1.46974290 |
| 73 | MP0001984_abnormal_olfaction | 1.46721282 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.46379842 |
| 75 | MP0003866_abnormal_defecation | 1.45643674 |
| 76 | MP0002132_abnormal_respiratory_system | 1.45027988 |
| 77 | MP0004924_abnormal_behavior | 1.45011650 |
| 78 | MP0005386_behavior/neurological_phenoty | 1.45011650 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 1.43299414 |
| 80 | MP0002398_abnormal_bone_marrow | 1.42708017 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.42034003 |
| 82 | MP0009764_decreased_sensitivity_to | 1.39067035 |
| 83 | MP0000013_abnormal_adipose_tissue | 1.38666459 |
| 84 | MP0005451_abnormal_body_composition | 1.38201437 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.35959382 |
| 86 | MP0003633_abnormal_nervous_system | 1.35120735 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 1.32789559 |
| 88 | MP0002166_altered_tumor_susceptibility | 1.32370457 |
| 89 | MP0004947_skin_inflammation | 1.30575991 |
| 90 | MP0001529_abnormal_vocalization | 1.29574684 |
| 91 | MP0003634_abnormal_glial_cell | 1.28297525 |
| 92 | MP0005174_abnormal_tail_pigmentation | 1.28081892 |
| 93 | MP0001851_eye_inflammation | 1.26858278 |
| 94 | MP0003122_maternal_imprinting | 1.26689670 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 1.23419616 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 1.20503348 |
| 97 | MP0003631_nervous_system_phenotype | 1.20381342 |
| 98 | MP0000689_abnormal_spleen_morphology | 1.19104511 |
| 99 | MP0002722_abnormal_immune_system | 1.18147627 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 1.18066925 |
| 101 | MP0008469_abnormal_protein_level | 1.17527303 |
| 102 | MP0001502_abnormal_circadian_rhythm | 1.17101342 |
| 103 | MP0001299_abnormal_eye_distance/ | 1.16916004 |
| 104 | MP0009278_abnormal_bone_marrow | 1.15950659 |
| 105 | MP0010386_abnormal_urinary_bladder | 1.14432797 |
| 106 | MP0004742_abnormal_vestibular_system | 1.14385101 |
| 107 | MP0010155_abnormal_intestine_physiology | 1.13858052 |
| 108 | MP0002396_abnormal_hematopoietic_system | 1.12375211 |
| 109 | MP0001986_abnormal_taste_sensitivity | 1.10344067 |
| 110 | MP0002229_neurodegeneration | 1.09914127 |
| 111 | MP0002822_catalepsy | 1.09788202 |
| 112 | MP0003690_abnormal_glial_cell | 1.09246752 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 1.07325050 |
| 114 | MP0001545_abnormal_hematopoietic_system | 1.07325050 |
| 115 | MP0003632_abnormal_nervous_system | 1.06712107 |
| 116 | MP0003283_abnormal_digestive_organ | 1.06652590 |
| 117 | MP0003879_abnormal_hair_cell | 1.05593665 |
| 118 | MP0002152_abnormal_brain_morphology | 1.05363232 |
| 119 | MP0002429_abnormal_blood_cell | 1.04150894 |
| 120 | MP0004142_abnormal_muscle_tone | 1.03247271 |
| 121 | MP0004484_altered_response_of | 1.02402306 |
| 122 | MP0000703_abnormal_thymus_morphology | 1.02031231 |
| 123 | MP0005310_abnormal_salivary_gland | 1.01625378 |
| 124 | MP0000858_altered_metastatic_potential | 1.01235888 |
| 125 | MP0005166_decreased_susceptibility_to | 0.99309215 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.98779401 |
| 127 | MP0000604_amyloidosis | 0.96688251 |
| 128 | MP0008961_abnormal_basal_metabolism | 0.94481086 |
| 129 | MP0005535_abnormal_body_temperature | 0.92889848 |
| 130 | MP0003183_abnormal_peptide_metabolism | 0.92675932 |
| 131 | MP0000569_abnormal_digit_pigmentation | 0.92467139 |
| 132 | MP0005248_abnormal_Harderian_gland | 0.91996385 |
| 133 | MP0002069_abnormal_eating/drinking_beha | 0.90313117 |
| 134 | MP0000631_abnormal_neuroendocrine_gland | 0.87221277 |
| 135 | MP0002752_abnormal_somatic_nervous | 0.87085370 |
| 136 | MP0001963_abnormal_hearing_physiology | 0.87083565 |
| 137 | MP0001905_abnormal_dopamine_level | 0.85404616 |
| 138 | MP0005388_respiratory_system_phenotype | 0.84150524 |
| 139 | MP0002133_abnormal_respiratory_system | 0.84150524 |
| 140 | MP0003252_abnormal_bile_duct | 0.83756141 |
| 141 | MP0001188_hyperpigmentation | 0.83351259 |
| 142 | MP0000751_myopathy | 0.82428278 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.81906216 |
| 144 | MP0001177_atelectasis | 0.81233714 |
| 145 | MP0005253_abnormal_eye_physiology | 0.80896855 |
| 146 | MP0002928_abnormal_bile_duct | 0.80881010 |
| 147 | MP0004043_abnormal_pH_regulation | 0.80770475 |
| 148 | MP0002090_abnormal_vision | 0.80553230 |
| 149 | MP0001958_emphysema | 0.79225092 |
| 150 | MP0006072_abnormal_retinal_apoptosis | 0.78316215 |
| 151 | MP0002009_preneoplasia | 0.77182534 |
| 152 | MP0005187_abnormal_penis_morphology | 0.75944288 |
| 153 | MP0004510_myositis | 0.75909146 |
| 154 | MP0003787_abnormal_imprinting | 0.75076675 |
| 155 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73668835 |
| 156 | MP0005058_abnormal_lysosome_morphology | 0.73454859 |
| 157 | MP0004085_abnormal_heartbeat | 0.73453029 |
| 158 | MP0001485_abnormal_pinna_reflex | 0.73289167 |
| 159 | MP0000579_abnormal_nail_morphology | 0.72617222 |
| 160 | MP0000371_diluted_coat_color | 0.72300394 |
| 161 | MP0002876_abnormal_thyroid_physiology | 0.68991965 |
| 162 | MP0002234_abnormal_pharynx_morphology | 0.68791530 |
| 163 | MP0005085_abnormal_gallbladder_physiolo | 0.67072200 |
| 164 | MP0003448_altered_tumor_morphology | 0.66374610 |
| 165 | MP0002006_tumorigenesis | 0.65985018 |
| 166 | MP0005409_darkened_coat_color | 0.64958502 |
| 167 | MP0002332_abnormal_exercise_endurance | 0.63947418 |
| 168 | MP0000249_abnormal_blood_vessel | 0.62992354 |
| 169 | MP0004130_abnormal_muscle_cell | 0.61459759 |
| 170 | MP0005171_absent_coat_pigmentation | 0.61326055 |
| 171 | MP0000026_abnormal_inner_ear | 0.60992337 |
| 172 | MP0009763_increased_sensitivity_to | 0.60775374 |
| 173 | MP0001943_abnormal_respiration | 0.60707795 |
| 174 | MP0000003_abnormal_adipose_tissue | 0.59294584 |
| 175 | MP0005394_taste/olfaction_phenotype | 0.59029255 |
| 176 | MP0005499_abnormal_olfactory_system | 0.59029255 |
| 177 | MP0001663_abnormal_digestive_system | 0.57799123 |
| 178 | MP0003195_calcinosis | 0.57570136 |
| 179 | MP0003861_abnormal_nervous_system | 0.56853671 |
| 180 | MP0000343_altered_response_to | 0.55706863 |
| 181 | MP0008874_decreased_physiological_sensi | 0.55254627 |
| 182 | MP0001944_abnormal_pancreas_morphology | 0.53759264 |
| 183 | MP0003045_fibrosis | 0.53474547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.21700282 |
| 2 | Focal motor seizures (HP:0011153) | 5.84140989 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.81660327 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.69918268 |
| 5 | Orchitis (HP:0100796) | 5.60415917 |
| 6 | Myositis (HP:0100614) | 5.51163467 |
| 7 | Optic neuritis (HP:0100653) | 5.48884121 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.48884121 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.02504576 |
| 10 | Myokymia (HP:0002411) | 4.97885617 |
| 11 | Action tremor (HP:0002345) | 4.85507446 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.64911610 |
| 13 | Focal seizures (HP:0007359) | 4.41919410 |
| 14 | Termporal pattern (HP:0011008) | 4.41082125 |
| 15 | Insidious onset (HP:0003587) | 4.41082125 |
| 16 | Stomatitis (HP:0010280) | 4.17346202 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 4.05963604 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 4.04153660 |
| 19 | Recurrent skin infections (HP:0001581) | 4.00737319 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.95882629 |
| 21 | Epileptic encephalopathy (HP:0200134) | 3.93485191 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.78483422 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.73637330 |
| 24 | Visual hallucinations (HP:0002367) | 3.73142778 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.72962652 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.67739185 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.67739185 |
| 28 | Hypochromic microcytic anemia (HP:0004840) | 3.63260359 |
| 29 | Atonic seizures (HP:0010819) | 3.58315358 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 3.58225354 |
| 31 | Ulnar claw (HP:0001178) | 3.57875069 |
| 32 | Neurofibrillary tangles (HP:0002185) | 3.56486160 |
| 33 | Gingivitis (HP:0000230) | 3.53148901 |
| 34 | Gingival bleeding (HP:0000225) | 3.43067280 |
| 35 | Meningitis (HP:0001287) | 3.35510066 |
| 36 | Febrile seizures (HP:0002373) | 3.35036531 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.34122055 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.30692176 |
| 39 | Encephalitis (HP:0002383) | 3.29686780 |
| 40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.28748287 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26640770 |
| 42 | Peritonitis (HP:0002586) | 3.24186095 |
| 43 | Hyperventilation (HP:0002883) | 3.23083426 |
| 44 | Absence seizures (HP:0002121) | 3.21910176 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 3.21651678 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 3.17393285 |
| 47 | Obstructive lung disease (HP:0006536) | 3.17393285 |
| 48 | Generalized tonic-clonic seizures (HP:0002069) | 3.16914360 |
| 49 | Urticaria (HP:0001025) | 3.11497591 |
| 50 | Hemoptysis (HP:0002105) | 3.08289905 |
| 51 | Poor eye contact (HP:0000817) | 3.05793350 |
| 52 | T lymphocytopenia (HP:0005403) | 3.05602354 |
| 53 | Amyloidosis (HP:0011034) | 3.03654866 |
| 54 | Arterial thrombosis (HP:0004420) | 3.01355631 |
| 55 | Broad-based gait (HP:0002136) | 2.98770248 |
| 56 | Excessive salivation (HP:0003781) | 2.98380072 |
| 57 | Drooling (HP:0002307) | 2.98380072 |
| 58 | Abnormality of T cell number (HP:0011839) | 2.97532869 |
| 59 | Vasculitis (HP:0002633) | 2.94688097 |
| 60 | Papilledema (HP:0001085) | 2.94553525 |
| 61 | Dialeptic seizures (HP:0011146) | 2.94228263 |
| 62 | Pulmonary embolism (HP:0002204) | 2.90158225 |
| 63 | Episodic fever (HP:0001954) | 2.89924104 |
| 64 | Chest pain (HP:0100749) | 2.87900514 |
| 65 | Hypochromic anemia (HP:0001931) | 2.85971113 |
| 66 | Amblyopia (HP:0000646) | 2.85926054 |
| 67 | Impaired social interactions (HP:0000735) | 2.84050383 |
| 68 | Abnormal social behavior (HP:0012433) | 2.84050383 |
| 69 | Truncal ataxia (HP:0002078) | 2.82237647 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.80449514 |
| 71 | Dysdiadochokinesis (HP:0002075) | 2.79223516 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.78939544 |
| 73 | Dysmetria (HP:0001310) | 2.77870859 |
| 74 | Intention tremor (HP:0002080) | 2.76140833 |
| 75 | Epileptiform EEG discharges (HP:0011182) | 2.74690968 |
| 76 | Ankle clonus (HP:0011448) | 2.72534959 |
| 77 | Depression (HP:0000716) | 2.70007029 |
| 78 | Megalencephaly (HP:0001355) | 2.69186643 |
| 79 | EEG with generalized epileptiform discharges (HP:0011198) | 2.67226521 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 2.65646216 |
| 81 | Increased IgE level (HP:0003212) | 2.65491212 |
| 82 | Pheochromocytoma (HP:0002666) | 2.64886539 |
| 83 | Leukocytosis (HP:0001974) | 2.60953786 |
| 84 | Abnormal eating behavior (HP:0100738) | 2.60322832 |
| 85 | Hemiparesis (HP:0001269) | 2.59386193 |
| 86 | Cellulitis (HP:0100658) | 2.59362225 |
| 87 | Hypsarrhythmia (HP:0002521) | 2.57082015 |
| 88 | Abnormality of the corticospinal tract (HP:0002492) | 2.51278945 |
| 89 | Anorexia (HP:0002039) | 2.51029505 |
| 90 | Gangrene (HP:0100758) | 2.49989724 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.48985375 |
| 92 | Spastic gait (HP:0002064) | 2.48654013 |
| 93 | Agitation (HP:0000713) | 2.48322633 |
| 94 | Gaze-evoked nystagmus (HP:0000640) | 2.46448826 |
| 95 | Epistaxis (HP:0000421) | 2.45848788 |
| 96 | Anxiety (HP:0000739) | 2.45493003 |
| 97 | Absent speech (HP:0001344) | 2.45374708 |
| 98 | Scanning speech (HP:0002168) | 2.42205295 |
| 99 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.41227854 |
| 100 | Abnormality of the endocardium (HP:0004306) | 2.40315092 |
| 101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.35525807 |
| 102 | Slow saccadic eye movements (HP:0000514) | 2.32659838 |
| 103 | Postural tremor (HP:0002174) | 2.31844914 |
| 104 | Onion bulb formation (HP:0003383) | 2.31433820 |
| 105 | Cheilitis (HP:0100825) | 2.30168257 |
| 106 | Urinary urgency (HP:0000012) | 2.27083253 |
| 107 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.23793879 |
| 108 | Osteomyelitis (HP:0002754) | 2.23596356 |
| 109 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.22924241 |
| 110 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.18648715 |
| 111 | Macroorchidism (HP:0000053) | 2.18608996 |
| 112 | Vertigo (HP:0002321) | 2.17810926 |
| 113 | Microcytic anemia (HP:0001935) | 2.17808481 |
| 114 | Blue irides (HP:0000635) | 2.17361729 |
| 115 | Difficulty running (HP:0009046) | 2.15623247 |
| 116 | Neuroendocrine neoplasm (HP:0100634) | 2.14763274 |
| 117 | Polyphagia (HP:0002591) | 2.14586257 |
| 118 | Hammertoe (HP:0001765) | 2.13440619 |
| 119 | Exotropia (HP:0000577) | 2.12494258 |
| 120 | Abnormality of the pleura (HP:0002103) | 2.11387458 |
| 121 | Lower limb muscle weakness (HP:0007340) | 2.09114450 |
| 122 | Sepsis (HP:0100806) | 2.08567025 |
| 123 | Progressive inability to walk (HP:0002505) | 2.07573189 |
| 124 | Acne (HP:0001061) | 2.04258600 |
| 125 | Mutism (HP:0002300) | 2.02301480 |
| 126 | Abnormality of T cells (HP:0002843) | 2.01839265 |
| 127 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.01394033 |
| 128 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.01394033 |
| 129 | Abnormality of salivation (HP:0100755) | 2.01307150 |
| 130 | Impaired smooth pursuit (HP:0007772) | 2.00531274 |
| 131 | Recurrent viral infections (HP:0004429) | 2.00413063 |
| 132 | Abnormality of the peritoneum (HP:0002585) | 1.99838964 |
| 133 | Limb dystonia (HP:0002451) | 1.98905667 |
| 134 | Genetic anticipation (HP:0003743) | 1.98392791 |
| 135 | Hemiplegia (HP:0002301) | 1.98295637 |
| 136 | Gait ataxia (HP:0002066) | 1.97919880 |
| 137 | Viral hepatitis (HP:0006562) | 1.97055917 |
| 138 | Insomnia (HP:0100785) | 1.96649548 |
| 139 | Abnormality of binocular vision (HP:0011514) | 1.95225762 |
| 140 | Diplopia (HP:0000651) | 1.95225762 |
| 141 | Abnormality of the lower motor neuron (HP:0002366) | 1.93737302 |
| 142 | Torticollis (HP:0000473) | 1.93655618 |
| 143 | Ocular albinism (HP:0001107) | 1.93575523 |
| 144 | Keratitis (HP:0000491) | 1.92992208 |
| 145 | Stereotypic behavior (HP:0000733) | 1.92278234 |
| 146 | Postural instability (HP:0002172) | 1.91536844 |
| 147 | Abnormal platelet volume (HP:0011876) | 1.90525027 |
| 148 | Granulocytopenia (HP:0001913) | 1.89041676 |
| 149 | Retinal dysplasia (HP:0007973) | 1.88155682 |
| 150 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.87938020 |
| 151 | Akinesia (HP:0002304) | 1.86893758 |
| 152 | Focal dystonia (HP:0004373) | 1.86736421 |
| 153 | Periodontitis (HP:0000704) | 1.85117967 |
| 154 | Steppage gait (HP:0003376) | 1.84913371 |
| 155 | Eosinophilia (HP:0001880) | 1.83902828 |
| 156 | Failure to thrive in infancy (HP:0001531) | 1.83472487 |
| 157 | Inflammation of the large intestine (HP:0002037) | 1.83441295 |
| 158 | Glomerulopathy (HP:0100820) | 1.81546860 |
| 159 | Increased CSF protein (HP:0002922) | 1.81364949 |
| 160 | Resting tremor (HP:0002322) | 1.80316102 |
| 161 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78588747 |
| 162 | Papillary thyroid carcinoma (HP:0002895) | 1.78199722 |
| 163 | Status epilepticus (HP:0002133) | 1.78164151 |
| 164 | Aqueductal stenosis (HP:0002410) | 1.77836234 |
| 165 | Clonus (HP:0002169) | 1.77058658 |
| 166 | Decreased motor nerve conduction velocity (HP:0003431) | 1.76746359 |
| 167 | Acute hepatic failure (HP:0006554) | 1.76591857 |
| 168 | Thickened helices (HP:0000391) | 1.75622713 |
| 169 | Aplasia involving bones of the extremities (HP:0009825) | 1.74351756 |
| 170 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.74351756 |
| 171 | Aplasia of the phalanges of the hand (HP:0009802) | 1.74351756 |
| 172 | Inability to walk (HP:0002540) | 1.74187896 |
| 173 | Bradykinesia (HP:0002067) | 1.73876437 |
| 174 | Thrombophlebitis (HP:0004418) | 1.73813702 |
| 175 | Spastic tetraplegia (HP:0002510) | 1.73456346 |
| 176 | Polycythemia (HP:0001901) | 1.72717822 |
| 177 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72201124 |
| 178 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72201124 |
| 179 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72201124 |
| 180 | Hypoplasia of the brainstem (HP:0002365) | 1.71609654 |
| 181 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.71609654 |
| 182 | Gastrointestinal inflammation (HP:0004386) | 1.71254679 |
| 183 | Increased cerebral lipofuscin (HP:0011813) | 1.70062761 |
| 184 | Loss of speech (HP:0002371) | 1.69738139 |
| 185 | Ventricular fibrillation (HP:0001663) | 1.68638163 |
| 186 | Abnormality of the pericardium (HP:0001697) | 1.68538617 |
| 187 | Joint swelling (HP:0001386) | 1.68137769 |
| 188 | Skin ulcer (HP:0200042) | 1.65379131 |
| 189 | Hypergammaglobulinemia (HP:0010702) | 1.64765708 |
| 190 | Interstitial pulmonary disease (HP:0006530) | 1.63182999 |
| 191 | Paresthesia (HP:0003401) | 1.62214792 |
| 192 | Skin rash (HP:0000988) | 1.60328627 |
| 193 | Memory impairment (HP:0002354) | 1.60221538 |
| 194 | Increased IgM level (HP:0003496) | 1.60037672 |
| 195 | Abnormality of eosinophils (HP:0001879) | 1.58621002 |
| 196 | Pustule (HP:0200039) | 1.58308537 |
| 197 | Chronic otitis media (HP:0000389) | 1.57988623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.94149602 |
| 2 | MAP3K9 | 3.65903051 |
| 3 | MARK1 | 3.33532178 |
| 4 | BLK | 3.22850315 |
| 5 | EPHA4 | 3.07239761 |
| 6 | MAP2K3 | 2.81809852 |
| 7 | IRAK4 | 2.68995482 |
| 8 | TYK2 | 2.64203442 |
| 9 | MAP3K4 | 2.53960735 |
| 10 | MINK1 | 2.51953489 |
| 11 | CSK | 2.51622804 |
| 12 | UHMK1 | 2.22991829 |
| 13 | NTRK1 | 2.20242904 |
| 14 | PRPF4B | 2.16313475 |
| 15 | CASK | 2.08450608 |
| 16 | MAP4K1 | 2.06998109 |
| 17 | EPHB1 | 2.02295847 |
| 18 | PAK6 | 2.02057730 |
| 19 | NTRK2 | 1.99570858 |
| 20 | KSR1 | 1.94731346 |
| 21 | GRK6 | 1.92146495 |
| 22 | DAPK2 | 1.91225824 |
| 23 | MAP2K7 | 1.89038571 |
| 24 | YES1 | 1.89001244 |
| 25 | PRKD3 | 1.86915953 |
| 26 | SIK3 | 1.85431379 |
| 27 | ERN1 | 1.76625432 |
| 28 | ZAP70 | 1.67614544 |
| 29 | BCR | 1.66943528 |
| 30 | KSR2 | 1.66901180 |
| 31 | TAOK1 | 1.62437272 |
| 32 | TNK2 | 1.60108235 |
| 33 | MAP2K4 | 1.58805451 |
| 34 | JAK2 | 1.58089819 |
| 35 | TXK | 1.57179216 |
| 36 | CDK5 | 1.56971781 |
| 37 | MAP3K3 | 1.56912534 |
| 38 | TAOK3 | 1.52871034 |
| 39 | HCK | 1.51856700 |
| 40 | SYK | 1.46687781 |
| 41 | JAK1 | 1.42706162 |
| 42 | CAMKK1 | 1.37879341 |
| 43 | JAK3 | 1.36907202 |
| 44 | INSRR | 1.36724961 |
| 45 | RIPK4 | 1.34429253 |
| 46 | MAPK13 | 1.33077284 |
| 47 | MAP3K12 | 1.32235648 |
| 48 | STK39 | 1.28962639 |
| 49 | MAP3K2 | 1.28608375 |
| 50 | BTK | 1.28583106 |
| 51 | MAP3K6 | 1.27658550 |
| 52 | IKBKE | 1.27180136 |
| 53 | SIK2 | 1.26505765 |
| 54 | MAP3K14 | 1.23669234 |
| 55 | OXSR1 | 1.23630319 |
| 56 | FGFR2 | 1.22608226 |
| 57 | PNCK | 1.17409799 |
| 58 | LYN | 1.15098918 |
| 59 | TNIK | 1.14435627 |
| 60 | TYRO3 | 1.13923490 |
| 61 | PLK2 | 1.13753116 |
| 62 | FGFR3 | 1.13254341 |
| 63 | PAK3 | 1.08776425 |
| 64 | DAPK1 | 1.05714086 |
| 65 | MAP3K13 | 1.02245084 |
| 66 | PHKG2 | 1.01496953 |
| 67 | PHKG1 | 1.01496953 |
| 68 | SGK223 | 1.01370355 |
| 69 | SGK494 | 1.01370355 |
| 70 | GRK5 | 1.01097365 |
| 71 | PRKCG | 1.00793497 |
| 72 | RET | 0.99724828 |
| 73 | WNK3 | 0.98358218 |
| 74 | FER | 0.97506177 |
| 75 | CAMK2A | 0.97077736 |
| 76 | CDK19 | 0.96069615 |
| 77 | RAF1 | 0.95952543 |
| 78 | CAMK1G | 0.93111152 |
| 79 | CAMK2B | 0.92483623 |
| 80 | MAP3K11 | 0.91624407 |
| 81 | CSF1R | 0.90849524 |
| 82 | EPHA3 | 0.88939393 |
| 83 | CAMKK2 | 0.88364054 |
| 84 | LRRK2 | 0.87791239 |
| 85 | CDK18 | 0.86321662 |
| 86 | LCK | 0.85820516 |
| 87 | IRAK2 | 0.85794367 |
| 88 | PIK3CG | 0.83467539 |
| 89 | WNK4 | 0.83351507 |
| 90 | MARK3 | 0.81887073 |
| 91 | CDK14 | 0.81788826 |
| 92 | PRKCH | 0.80665368 |
| 93 | MARK2 | 0.79465303 |
| 94 | ITK | 0.78321865 |
| 95 | WNK1 | 0.78239299 |
| 96 | PTK6 | 0.76776613 |
| 97 | CDK15 | 0.76429968 |
| 98 | TGFBR2 | 0.75893399 |
| 99 | STK11 | 0.73211384 |
| 100 | FES | 0.72719296 |
| 101 | TEC | 0.72496229 |
| 102 | CSNK1G2 | 0.71973407 |
| 103 | MAPK12 | 0.71691308 |
| 104 | MATK | 0.70435440 |
| 105 | DYRK1A | 0.69708691 |
| 106 | KIT | 0.69360207 |
| 107 | FGR | 0.69296401 |
| 108 | ERBB3 | 0.68803690 |
| 109 | TBK1 | 0.67701455 |
| 110 | STK38 | 0.66355591 |
| 111 | PRKCE | 0.66155292 |
| 112 | SGK1 | 0.63958628 |
| 113 | CDK11A | 0.63194298 |
| 114 | MAP3K7 | 0.63127307 |
| 115 | CAMK2D | 0.62244671 |
| 116 | PRKD2 | 0.60267899 |
| 117 | IRAK1 | 0.60083168 |
| 118 | MAP3K5 | 0.59450420 |
| 119 | PKN1 | 0.59380306 |
| 120 | BMPR2 | 0.58689940 |
| 121 | SGK2 | 0.58632918 |
| 122 | MAP3K1 | 0.57241410 |
| 123 | PDGFRA | 0.57214498 |
| 124 | CAMK4 | 0.55907120 |
| 125 | PTK2B | 0.55895645 |
| 126 | FYN | 0.55416684 |
| 127 | PRKCZ | 0.53543468 |
| 128 | STK10 | 0.51810046 |
| 129 | ROCK2 | 0.51210405 |
| 130 | MAP2K6 | 0.50610849 |
| 131 | DYRK2 | 0.50218739 |
| 132 | PDPK1 | 0.50154463 |
| 133 | EPHB2 | 0.49546025 |
| 134 | MAPK7 | 0.49126421 |
| 135 | DYRK1B | 0.48785129 |
| 136 | NEK6 | 0.48662420 |
| 137 | DMPK | 0.48588392 |
| 138 | ICK | 0.47997807 |
| 139 | CAMK1 | 0.46386775 |
| 140 | SGK3 | 0.45822361 |
| 141 | PDK1 | 0.45431264 |
| 142 | RPS6KA3 | 0.45355691 |
| 143 | LMTK2 | 0.45201445 |
| 144 | PDGFRB | 0.44729239 |
| 145 | PRKD1 | 0.43051633 |
| 146 | CDC42BPA | 0.42464343 |
| 147 | FGFR4 | 0.42272993 |
| 148 | LATS2 | 0.41700532 |
| 149 | CAMK2G | 0.41643010 |
| 150 | MAPK10 | 0.41442594 |
| 151 | HIPK2 | 0.40471336 |
| 152 | PTK2 | 0.39747032 |
| 153 | PRKCQ | 0.39520970 |
| 154 | MAP2K1 | 0.39465090 |
| 155 | NLK | 0.39258811 |
| 156 | FRK | 0.38789640 |
| 157 | PRKG1 | 0.35243729 |
| 158 | PRKCB | 0.34863666 |
| 159 | ERBB2 | 0.32824652 |
| 160 | RIPK1 | 0.31316547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.01359544 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.70738286 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.59542670 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42856834 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42439789 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.40094188 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36795881 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.34512685 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33653005 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.29795275 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.11797271 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06205795 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.06007485 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.05236438 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04998035 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01730085 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.01711307 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.00666949 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.98571380 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.86988814 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86533378 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83330797 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.83148873 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73554795 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.68707249 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65179337 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63976329 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.63937902 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62874115 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60888493 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57364839 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.56894709 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.56843815 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48029652 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47274824 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46396892 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.44292008 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44229877 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44193256 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41071625 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.40675222 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35739324 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33689525 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32262899 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.31925607 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.31029593 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27509657 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26903949 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26866863 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.25620656 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 1.23903966 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.23238256 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22869409 |
| 54 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21764160 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 1.20286325 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20251971 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.17047980 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15746608 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14184731 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12457691 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12155294 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 1.11637937 |
| 63 | Glioma_Homo sapiens_hsa05214 | 1.11235793 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11061838 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10058008 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09254112 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.09205073 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06988509 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06807979 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05826905 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 1.04973201 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03862005 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03035524 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 1.02730306 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 1.01743887 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99716428 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99123929 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99003739 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98013047 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97002393 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96232220 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95248600 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94517443 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93278062 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92461038 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.92362134 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91884091 |
| 88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87251046 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86366317 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.85174751 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85109347 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84934065 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81977844 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81974215 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80085051 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78286770 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78232403 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77706425 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76915948 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.70963353 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70854795 |
| 102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69952083 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69168038 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67535920 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66991933 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66972528 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66556826 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.65680252 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65640358 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64363632 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.64330281 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63557941 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.63178574 |
| 114 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62705787 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62626833 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62609782 |
| 117 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62127221 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62112551 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.61870853 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61797370 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60424384 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.59872925 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59711211 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59523688 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59167026 |
| 126 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57221601 |
| 127 | Lysosome_Homo sapiens_hsa04142 | 0.57205688 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56429223 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56016229 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55515836 |
| 131 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54416234 |
| 132 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53800920 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53648017 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.53546493 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52077160 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51131714 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50864248 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49619044 |
| 139 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49371189 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47974776 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45915430 |
| 142 | Alcoholism_Homo sapiens_hsa05034 | 0.45686814 |
| 143 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45198286 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.43551240 |
| 145 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43540261 |
| 146 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42815719 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41681238 |
| 148 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41494434 |
| 149 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40334202 |
| 150 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40096317 |
| 151 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38312381 |
| 152 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38285596 |
| 153 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37269511 |
| 154 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36441870 |
| 155 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36042536 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35328187 |
| 157 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34994005 |
| 158 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33219156 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32888508 |
| 160 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31621481 |

